Stock Track | Pro Medicus Soars 5.63% Intraday on Major A$90M Contract Win with Beth Israel Lahey Health
Stock Track
May 18
Pro Medicus Ltd's stock surged 5.63% during Monday's intraday trading session following the announcement of a significant new contract.
The medical imaging technology company signed a 7-year deal worth A$90 million with Beth Israel Lahey Health, providing a substantial boost to its future revenue pipeline. The contract encompasses the company's full stack of Visage 7 products, including the Visage 7 Viewer, Visage 7 Workflow, and Visage 7 Open Archive solutions.
This major contract win represents a significant validation of Pro Medicus's technology platform and is expected to contribute meaningfully to the company's financial performance over the coming years, driving investor optimism and the stock's upward movement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.